Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
Clinical trial NCT05643534 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05643534
- Sponsor
- Ardelyx
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-15
- Primary completion
- 2026-09-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.